BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29280311)

  • 21. Endosomolytic bioreducible poly(amido amine disulfide) polymer conjugates for the in vivo systemic delivery of siRNA therapeutics.
    Parmar RG; Busuek M; Walsh ES; Leander KR; Howell BJ; Sepp-Lorenzino L; Kemp E; Crocker LS; Leone A; Kochansky CJ; Carr BA; Garbaccio RM; Colletti SL; Wang W
    Bioconjug Chem; 2013 Apr; 24(4):640-7. PubMed ID: 23496378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy.
    Li H; Yang X; Gao F; Qian C; Li C; Oupicky D; Sun M
    J Control Release; 2018 Dec; 292():78-90. PubMed ID: 29499219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol.
    Jackson MA; Werfel TA; Curvino EJ; Yu F; Kavanaugh TE; Sarett SM; Dockery MD; Kilchrist KV; Jackson AN; Giorgio TD; Duvall CL
    ACS Nano; 2017 Jun; 11(6):5680-5696. PubMed ID: 28548843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
    Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
    Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of poly(amido amine)s as vectors for siRNA delivery.
    van der Aa LJ; Vader P; Storm G; Schiffelers RM; Engbersen JF
    J Control Release; 2011 Mar; 150(2):177-86. PubMed ID: 21130817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing.
    Sarett SM; Werfel TA; Chandra I; Jackson MA; Kavanaugh TE; Hattaway ME; Giorgio TD; Duvall CL
    Biomaterials; 2016 Aug; 97():122-32. PubMed ID: 27163624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible Covalent Cross-Linked Polycations with Enhanced Stability and ATP-Responsive Behavior for Improved siRNA Delivery.
    Zhou Z; Zhang M; Liu Y; Li C; Zhang Q; Oupicky D; Sun M
    Biomacromolecules; 2018 Sep; 19(9):3776-3787. PubMed ID: 30081638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
    Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional triblock Nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing.
    Patil ML; Zhang M; Minko T
    ACS Nano; 2011 Mar; 5(3):1877-87. PubMed ID: 21322531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists.
    Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D
    Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel bioreducible poly(amido amine)s for highly efficient gene delivery.
    Lin C; Zhong Z; Lok MC; Jiang X; Hennink WE; Feijen J; Engbersen JF
    Bioconjug Chem; 2007; 18(1):138-45. PubMed ID: 17226966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel endosomolytic poly(amido amine) polymer conjugates for systemic delivery of siRNA to hepatocytes in rodents and nonhuman primates.
    Parmar RG; Poslusney M; Busuek M; Williams JM; Garbaccio R; Leander K; Walsh E; Howell B; Sepp-Lorenzino L; Riley S; Patel M; Kemp E; Latham A; Leone A; Soli E; Burke RS; Carr B; Colletti SL; Wang W
    Bioconjug Chem; 2014 May; 25(5):896-906. PubMed ID: 24742200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioreducible-Cationic Poly(amido amine)s for Enhanced Gene Delivery and Osteogenic Differentiation of Tonsil-Derived Mesenchymal Stem Cells.
    Jeong H; Lee ES; Jung G; Park J; Jeong B; Ryu KH; Hwang NS; Lee H
    J Biomed Nanotechnol; 2016 May; 12(5):1023-34. PubMed ID: 27305823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioreducible hyperbranched poly(amido amine)s for gene delivery.
    Chen J; Wu C; Oupický D
    Biomacromolecules; 2009 Oct; 10(10):2921-7. PubMed ID: 19743843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disulfide-based poly(amido amine)s for siRNA delivery: effects of structure on siRNA complexation, cellular uptake, gene silencing and toxicity.
    Vader P; van der Aa LJ; Engbersen JF; Storm G; Schiffelers RM
    Pharm Res; 2011 May; 28(5):1013-22. PubMed ID: 21181546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spermine-Based Poly(β-amino ester)s for siRNA Delivery against Mutated KRAS in Lung Cancer.
    Jin Y; Adams F; Isert L; Baldassi D; Merkel OM
    Mol Pharm; 2023 Sep; 20(9):4505-4516. PubMed ID: 37578116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes.
    Sonoke S; Ueda T; Fujiwara K; Sato Y; Takagaki K; Hirabayashi K; Ohgi T; Yano J
    Cancer Res; 2008 Nov; 68(21):8843-51. PubMed ID: 18974128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disulfide-functional poly(amido amine)s with tunable degradability for gene delivery.
    Elzes MR; Akeroyd N; Engbersen JF; Paulusse JM
    J Control Release; 2016 Dec; 244(Pt B):357-365. PubMed ID: 27565216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate.
    Meyer M; Dohmen C; Philipp A; Kiener D; Maiwald G; Scheu C; Ogris M; Wagner E
    Mol Pharm; 2009; 6(3):752-62. PubMed ID: 19348503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.